Ribosomes are the protein-building machines found in every animal cell, and a typical human cell contains roughly ten million of them. Each ribosome reads genetic instructions carried by messenger RNA and links amino acids together into proteins, making ribosomes essential for virtually every process a cell carries out. But ribosomes are not all identical, they do not all sit in the same place, and the cell invests a staggering amount of energy keeping them running. Understanding where they are, how they are built, and what can go wrong with them reveals a lot about how animal cells actually work.
What an 80S Ribosome Looks Like
Animal cell ribosomes belong to the 80S class, meaning they sediment at 80 Svedberg units when spun in a centrifuge. Each ribosome is made of two unequal halves: a small 40S subunit and a large 60S subunit. (Svedberg units do not add up the way you might expect because they reflect shape and density, not just mass.) The small subunit carries the 18S ribosomal RNA along with about 32 proteins, while the large subunit contains three RNA molecules (25S or 28S, 5.8S, and 5S) plus around 45 proteins.1Cell. Structure of the Functional Eukaryotic 80S Ribosome at 15.4 Å Resolution Compared with bacterial ribosomes, which are the 70S type, eukaryotic ribosomes have extra RNA insertions and a dozen or more additional proteins in each subunit. Those extra components create surface features and internal channels that bacteria lack.
Recent cryo-electron microscopy work has resolved the human 80S ribosome down to 1.9 ångström resolution, fine enough to see individual water molecules and metal ions like zinc, potassium, and magnesium threaded throughout the structure.2PubMed. The structure of the human 80S ribosome at 1.9 Å resolution reveals the molecular role of chemical modifications and ions in RNA Those ions are not decorative. They stabilize the folds of ribosomal RNA and help hold the two subunits together at their interface. The core functional sites, particularly the peptidyl transferase center where new amino acids are joined and the decoding center where messenger RNA is read, are highly conserved across species. Even the ribosome of the ancient parasite Giardia, which diverged from other eukaryotes very early, preserves the same architecture at those critical spots.3Nucleic Acids Research. Cryo-EM structure of the ancient eukaryotic ribosome from the human parasite Giardia lamblia
Where Ribosomes Are Found Inside Animal Cells
Ribosomes show up in several distinct locations within an animal cell, and where they sit determines what kind of protein they are making.
- Free in the cytoplasm: These ribosomes float in the cell’s interior fluid and generally produce proteins that will stay inside the cytoplasm or move to the nucleus, mitochondria, or peroxisomes.
- Bound to the endoplasmic reticulum: Ribosomes studding the rough ER translate proteins destined for secretion, the cell membrane, or organelles like lysosomes. The ribosome docks on the ER membrane when a signal sequence on the growing protein chain is recognized by a receptor complex.
- Inside mitochondria: Animal cell mitochondria carry their own dedicated ribosomes, which are structurally distinct from the 80S ribosomes in the cytoplasm.
- At synapses in neurons: Nerve cells shuttle ribosomes and mRNAs far from the cell body into dendrites and axons, enabling local protein production right at the synapse.
The distinction between “free” and “bound” is not permanent. After a ribosome finishes translating a protein on the ER, the small subunit tends to release back into the cytoplasm while the large subunit stays attached to the membrane for a time.4Journal of Biological Chemistry. The Fate of Membrane-bound Ribosomes Following the Termination of Protein Synthesis This means ribosomes cycle between pools rather than being locked into one location. The cell can shift the balance depending on how much secretory or membrane protein it needs at any moment.
Local Translation in Neurons
Neurons are an extreme case of ribosome distribution. A single motor neuron can extend an axon a meter long, yet it has only one nucleus back in the cell body. Waiting for every protein to be made centrally and shipped down the axon would be far too slow for the rapid changes synapses need during learning and memory formation. Instead, neurons transport specific mRNAs into their processes and rely on ribosomes stationed locally to translate those messages on demand.5PubMed Central. Local Protein Synthesis at Synapses: A Driver for Synapse Diversification This local protein synthesis lets individual synapses remodel their protein landscape independently of the rest of the neuron, which is thought to be a key part of how synapses strengthen or weaken during plasticity.
The Mitochondrial Ribosome
Mitochondria have their own genome and their own translation machinery, a legacy of the ancient bacterium that became an endosymbiont inside early eukaryotic cells. The mammalian mitochondrial ribosome, called the 55S mitoribosome, is dramatically different from the 80S ribosome working out in the cytoplasm.6PubMed Central. The 55S mammalian mitochondrial ribosome and its tRNA-exit region Over evolutionary time, mitochondrial ribosomal RNA has shrunk significantly while the number and size of mitoribosomal proteins have expanded. The result is a ribosome whose protein-to-RNA ratio is roughly 69-to-31, essentially the inverse of a bacterial ribosome’s ratio of about 33-to-67.7PubMed. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins
You might expect that all those extra proteins simply fill in where RNA was lost, but structural work shows they actually occupy new positions, creating features that bacterial and cytoplasmic ribosomes do not have. Mitoribosomes have a gate-like structure at the mRNA entrance that may help recruit the unusual mitochondrial mRNAs (which lack the cap structures seen on cytoplasmic mRNAs), and they have a modified polypeptide exit tunnel that exposes the growing protein chain to the surrounding fluid before the standard exit site. The bridges connecting the two mitoribosomal subunits are built mostly of protein rather than RNA, another departure from the cytoplasmic model.7PubMed. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins Despite all these differences, the core catalytic centers for decoding mRNA and forming peptide bonds remain conserved.
How Ribosomes Are Built
Building a ribosome is one of the most resource-intensive things an animal cell does. The process begins in the nucleolus, a dense region inside the nucleus that exists primarily for this purpose. There, ribosomal DNA is transcribed into a long precursor RNA, which is then chemically modified and cut into the mature rRNA molecules that will become part of the 40S and 60S subunits.8PubMed Central. The Nucleolus: A Central Hub for Ribosome Biogenesis and Cellular Regulatory Signals Ribosomal proteins, meanwhile, are made by cytoplasmic ribosomes (the existing generation of ribosomes builds the next), imported into the nucleus, and combined with the rRNA precursors in the nucleolus.
The assembly pathway requires hundreds of helper proteins. A systematic study in human cells identified 286 nucleolar proteins required for proper rRNA processing, including 74 that have no equivalent in yeast, indicating that mammalian ribosome assembly has added layers of complexity beyond what simpler organisms use.9Molecular Cell. Probing the Human Nucleolar Proteome to Identify Mammalian Ribosome Biogenesis Factors Specific factors are needed at particular steps; for example, the protein BCCIP is required to recruit the factor eIF6 into the nucleolus for a processing step that generates the 5.8S rRNA component of the large subunit.10PubMed Central. BCCIP is required for nucleolar recruitment of eIF6 and 12S pre-rRNA production during 60S ribosome biogenesis
Once the pre-ribosomal subunits reach a sufficiently mature state, they are exported through nuclear pores into the cytoplasm. This export depends on the transport receptor CRM1 and the energy of RanGTP.11PubMed. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway Real-time imaging has captured individual pre-60S subunits passing through a single nuclear pore in about 24 milliseconds on average.12Nature Communications. Nuclear export of the pre-60S ribosomal subunit through single nuclear pores observed in real time Final maturation steps occur in the cytoplasm, ensuring that only fully functional subunits join the translating pool.
How Translation Works
Protein synthesis on the ribosome unfolds in three phases. During initiation, a capped mRNA is loaded onto the 40S small subunit with the help of a team of initiation factors. The small subunit then scans along the mRNA until it finds the start codon.13PubMed Central. Structure of a human cap-dependent 48S translation pre-initiation complex At that point the large 60S subunit joins, forming the complete 80S ribosome, and elongation begins: the ribosome moves along the mRNA three nucleotides at a time, matching each codon to its transfer RNA and adding the corresponding amino acid to the growing chain.
Termination happens when the ribosome reaches a stop codon. Two release factors, eRF1 and eRF3, bind together and recognize the stop signal, triggering a tightly regulated, multi-step process that frees the finished protein and splits the ribosome back into its subunits for reuse.14PubMed Central. Mechanisms that ensure speed and fidelity in eukaryotic translation termination The parallels between stop-codon recognition and normal tRNA selection during elongation suggest the ribosome uses a similar proofreading logic at both stages.
The Energy Cost of Making Ribosomes
Ribosome production dominates a growing cell’s energy budget. In a rapidly dividing yeast cell, ribosomal proteins account for roughly half of all protein molecules and about 30% of total protein mass. Human cells are less extreme but still devote an estimated 4 to 6% of their total protein mass to ribosomal proteins, and a typical human cell maintains around ten million ribosomes.15Current Biology. Ribosome biogenesis and the cellular energy economy The energy investment does not end at assembly. A large fraction of newly made ribosomal proteins never make it into a finished ribosome and are degraded by the proteasome. In HeLa cells, degrading excess ribosomal proteins alone consumes on the order of 1012 ATP molecules per cell generation.16Current Biology. Building Ribosomes: Even More Expensive Than Expected? This is an enormous overhead, and it explains why cells tightly regulate ribosome production in response to nutrient availability and growth signals.
Not All Ribosomes Are the Same
For decades, ribosomes were treated as interchangeable machines: hand them any mRNA and they would translate it with equal enthusiasm. That picture has shifted. Differences in which ribosomal proteins are present, how those proteins are chemically modified after they are made, variation in the rRNA itself, and which accessory factors are riding along can all generate what researchers call “specialized ribosomes.”17PubMed Central. Specialized ribosomes: a new frontier in gene regulation and organismal biology These variant ribosomes do not translate every mRNA with equal efficiency; some preferentially translate certain messages over others, adding a previously unappreciated layer of gene regulation.
One well-studied modification involves the phosphorylation of ribosomal protein S6. When S6 is phosphorylated by the kinase that responds to insulin and growth factor signaling, translation of specific mRNAs can be stimulated several-fold compared to unmodified ribosomes.18Journal of Biological Chemistry. Phosphorylation of ribosomal protein S6 by cAMP-dependent protein kinase and mitogen-stimulated S6 kinase differentially alters translation of globin mRNA The P-stalk proteins on the large subunit are another example: they exist in a constantly phosphorylated state, and this phosphorylation keeps the ribosome running at optimal speed and accuracy by giving the stalk’s tail regions enough flexibility to interact with incoming translation factors.19PubMed Central. Phosphorylation of P-stalk proteins defines the ribosomal state for interaction with auxiliary protein factors
Quality Control When Translation Stalls
Ribosomes sometimes get stuck. A damaged mRNA, a problematic sequence, or a missing stop codon can cause the ribosome to stall mid-translation, leaving a half-finished, potentially toxic protein still attached. Animal cells have a surveillance system called ribosome-associated quality control (RQC) to deal with this. When a stall is detected, the ribosome is split, and the protein NEMF (along with the E3 ubiquitin ligase Listerin) tags the incomplete polypeptide for destruction by the proteasome.20PubMed Central. Ribosome-associated quality-control mechanisms from bacteria to humans This mechanism is conserved from bacteria to humans, underscoring how important it is to prevent garbled proteins from accumulating.
Entire ribosomes that are damaged or no longer needed can also be selectively removed through a process called ribophagy, a specialized form of autophagy. Cells use specific receptor proteins to recognize ribosomes marked for disposal and deliver them to lysosomes for recycling, often ramping up ribophagy during nutrient starvation when the cell needs to cannibalize its own components.21PubMed Central. Selective Autophagy of the Protein Homeostasis Machinery: Ribophagy, Proteaphagy and ER-Phagy
What Happens When Ribosomes Go Wrong
Mutations in ribosomal protein genes cause a class of diseases called ribosomopathies. The best-known example is Diamond-Blackfan anemia (DBA), in which patients carry a defective copy of one of at least 24 different ribosomal protein genes.22PubMed. Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies? Having only one working copy of a ribosomal protein gene (haploinsufficiency) disrupts rRNA processing and leads to fewer functional ribosomes overall. Puzzlingly, the most affected cell type is the red blood cell precursor, even though ribosomes are needed everywhere. Recent work suggests that the deficit hits a stress-response regulator called ATF4 especially hard in early blood-forming cells, and this effect is more severe when the mutant gene encodes a small-subunit protein because losing 40S subunits also destabilizes ATF4 mRNA itself.23PubMed Central. Ribosomal protein deficiencies linked to Diamond-Blackfan anemia induce distinctive alterations of ATF4 expression DBA patients also face an elevated cancer risk later in life, linking ribosome defects to malignancy as well as to anemia.
Pathogens That Target the Ribosome
Because protein synthesis is essential for cell survival, the ribosome is a prime target for toxins and pathogens. Ricin, the plant toxin found in castor beans, works by clipping a single adenine base from a highly conserved loop on the large subunit’s rRNA called the sarcin-ricin loop.24PubMed Central. How Ricin Damages the Ribosome That one tiny chemical change is enough to shut down the ribosome’s ability to interact with elongation factors, halting translation and killing the cell. Fungal ribotoxins achieve a similar result by directly cleaving the same loop.25PubMed Central. Ribosome-inactivating proteins: potent poisons and molecular tools
Viruses take a different approach. Rather than destroying the ribosome, many viruses hijack it. Some viral RNAs contain internal ribosome entry sites (IRES), structured RNA elements that latch directly onto the ribosome and bypass the normal cap-dependent initiation process, giving the virus’s messages priority access to the translation machinery.26PubMed Central. Viral IRES RNA structures and ribosome interactions SARS-CoV-2 uses yet another trick: a conserved RNA structure in its genome forces translating ribosomes to slip backward by one nucleotide (programmed ribosomal frameshifting), allowing the virus to produce essential replication proteins from a single mRNA. A CRISPR screen found that losing the cell’s ribosome-recycling factors sharply reduces this frameshifting and impairs viral replication, pointing to ribosome recycling as a potential therapeutic vulnerability.27PubMed Central. CRISPR screening reveals a dependency on ribosome recycling for efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication
Ribosomes as Drug Targets
The structural differences between human and bacterial ribosomes are the reason conventional antibiotics can kill bacteria without harming your cells. But those same structural details are now being explored for cancer therapy. Cancer cells are often addicted to high rates of protein synthesis, and their ribosome biogenesis is cranked up accordingly.28PubMed Central. Ribosome-Directed Therapies in Cancer Researchers have tested antibiotics that specifically bind the eukaryotic ribosome (as opposed to the bacterial one) and found that several of them kill leukemic cells at nanomolar concentrations while sparing normal cells, because the cancer cells’ survival depends more heavily on maximal translation output. In one study, the drug homoharringtonine showed an IC50 of 15 nM against leukemic cells, while antibiotics that bind only the prokaryotic ribosome had no effect on the same cells.29Nature Communications. Structure–function insights reveal the human ribosome as a cancer target for antibiotics Homoharringtonine is already approved for treating certain forms of leukemia, and ongoing work is mapping which ribosomal binding sites offer the best selectivity for cancer cells over healthy tissue.
The broader strategy of disrupting ribosome biogenesis rather than the ribosome itself is also under investigation. Since cancer cells need a constant supply of new ribosomes to sustain their rapid growth, drugs that interfere with rRNA transcription or processing in the nucleolus can slow tumor proliferation. The challenge is finding a therapeutic window where the drug hits cancer cells harder than normal dividing cells, a problem that echoes the classic difficulty with all chemotherapy.